Researchers have identified a promising new compound that has appeared to slow down a process that fuels breast cancer in mice a discovery that could have implications in treating a host of cancers. Apart from short-circuiting the proliferation of cancer cells the new agent which the researchers called Fasnall also contributed to the death of existing cancer cells the researchers said. The findings showed that mice injected with the Fasnall survived for an average of 63 days more than double the lifespan of the mice in the control group. After three weeks tumours in the mice that received Fasnall were
